Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanako Yasuda

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The British Journal of Ophthalmology|September 4, 2014
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusionMasahiko Shimura, Kanako Yasuda
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 14, 2011
A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathyKanako Yasuda, Akiko Miyazawa, Masahiko Shimura
Journal of Clinical Medicine|October 30, 2020
Cytokines and Pathogenesis of Central Retinal Vein OcclusionHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Ophthalmology|February 7, 2006
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good visionMasahiko Shimura, Kanako Yasuda, Takashi Shiono
European Journal of Ophthalmology|November 7, 2019
Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edemaHidetaka Noma, Kanako Yasuda, Masahiko Shimura
International Journal of Molecular Sciences|April 3, 2021
Involvement of Cytokines in the Pathogenesis of Diabetic Macular EdemaHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Journal of Ophthalmology|June 14, 2019
Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein OcclusionHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Japanese Journal of Ophthalmology|June 17, 2016
Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edemaMasahiko Shimura, Kanako Yasuda, Teruumi Minezaki, et al.
Retina (Philadelphia, Pa.)|February 12, 2016
POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSIONHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
Ophthalmic Research|May 11, 2016
Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular OedemaHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The British Journal of Ophthalmology|September 4, 2014
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusionMasahiko Shimura, Kanako Yasuda
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 14, 2011
A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathyKanako Yasuda, Akiko Miyazawa, Masahiko Shimura
Journal of Clinical Medicine|October 30, 2020
Cytokines and Pathogenesis of Central Retinal Vein OcclusionHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Ophthalmology|February 7, 2006
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good visionMasahiko Shimura, Kanako Yasuda, Takashi Shiono
European Journal of Ophthalmology|November 7, 2019
Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edemaHidetaka Noma, Kanako Yasuda, Masahiko Shimura
International Journal of Molecular Sciences|April 3, 2021
Involvement of Cytokines in the Pathogenesis of Diabetic Macular EdemaHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Journal of Ophthalmology|June 14, 2019
Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein OcclusionHidetaka Noma, Kanako Yasuda, Masahiko Shimura
Japanese Journal of Ophthalmology|June 17, 2016
Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edemaMasahiko Shimura, Kanako Yasuda, Teruumi Minezaki, et al.
Retina (Philadelphia, Pa.)|February 12, 2016
POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSIONHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
Ophthalmic Research|May 11, 2016
Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular OedemaHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
Pageof 7